Nath Bio-Genes (India) Ltd
- P/E
- 7.5x
- 52-week range
- 126.15 – 204
- ROE
- 5%
- ROCE
- 7%
- Sector
- Agricultural Food & other Products
- Industry
- Other Agricultural Products
- Listed on
- NSE, BSE
About
Nath Bio-Genes (India) Limited is an India-based company, which is engaged in the business of production, processing, and marketing of hybrid and GM Seeds. The Company has a product range of field crops, vegetable crops and plant nutrient supplements. The major processing plants are situated at Aurangabad (MS), and Munipalli, Nizamabad (TG). The Company’s product categories include oilseeds and fiber, field crops, vegetables, and plant nutrition. Its fiber and oil seeds include cotton and mustard. The Company's vegetable crop range includes chili, okra, tomato, bottle gourd, bitter gourd, cucumber, coriander, pumpkin, and others. Its field crops include corn, jowar, hybrid paddy, research paddy and wheat. Its plant nutrition products include WINPro GOLii, WINall and Win Chin Win. The Company’s forage products include NUTRIMAX and NUTRIMAX GOLD. It has seed processing facilities and processing plants located in Maharashtra, Telangana, and Andhra Pradesh.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Other Agricultural Products: 90 companies →Nath Bio-Genes (India) Ltd against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)7.5 against a typical 14.5: cheaper than most peers (1st = cheapest).14th of 88
- Sales growth+15.5% against a typical +19.1% from a year earlier.37th of 68
- Profit growth+14.3% against a typical +5.4% from a year earlier.26th of 59
- Share price, 3 months−16.9% against a typical −1.7%.61st of 81
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
Moderate safety, with caution
Rated BBB+ by India Ratings- No warnings from the agency.
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| India Ratings | IND BBB+; IND A2 | Stable | 1 Sep 2026 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 1 Sep 2026 | New rating | IND BBB+ | — | India Ratings | ₹ 45 Cr. |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 29 Jul 2026 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 |
| 4 May 2026 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2026 and dividend |
| 31 Jan 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 |
| 13 Nov 2025 | Financial Results | To consider and approve the financial results for the period ended September 30, 2025 |
| 11 Jul 2025 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2025 |
| 29 Apr 2025 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2025 and dividend |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 23 | 32 | 43 | 244 | 32 | 37 | 52 | 284 | 44 | 66 | 52 | 328 |
| Expenses | 18 | 26 | 39 | 207 | 27 | 29 | 52 | 254 | 38 | 62 | 47 | 293 |
| Operating Profit | 5 | 6 | 4 | 37 | 5 | 8 | 0 | 29 | 6 | 4 | 4 | 35 |
| OPM % | 22% | 18% | 9% | 15% | 15% | 22% | 0.8% | 10% | 14% | 5% | 9% | 11% |
| Other Income | 0 | 3 | 1 | 0 | 0 | 0 | 4 | 4 | 4 | 4 | 4 | 3 |
| Interest | 2 | 3 | 1 | 2 | 3 | 4 | 1 | 3 | 4 | 5 | 5 | 4 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 2 | 5 | 3 | 34 | 1 | 4 | 2 | 29 | 5 | 2 | 2 | 33 |
| Tax % | 19% | 17% | 19% | 1% | −3% | 30% | 30% | 2% | 12% | 35% | 100% | 2% |
| Net Profit | 2 | 4 | 3 | 33 | 1 | 3 | 1 | 28 | 5 | 2 | 0 | 32 |
| EPS in Rs | 0.79 | 2.02 | 1.38 | 17.55 | 0.58 | 1.39 | 0.78 | 14.88 | 2.54 | 0.84 | −0.01 | 16.98 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- —
- 3 Years
- 24%
- TTM
- 21%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- 1%
- TTM
- 9%
- 10 Years
- 4%
- 5 Years
- −13%
- 3 Years
- −11%
- TTM
- —
- 10 Years
- —
- 5 Years
- 6%
- 3 Years
- 6%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Nath Bio-Genes (India) Ltd | ₹ 133.00 | — | 7.5x | — | 5% | — |
| Kaveri Seed Company | ₹ 731.00 | ₹ 3,752 Cr. | 12.6x | 2.1x | 0% | 0% |
| Amir Chand Jagdish Kumar (Exports) Ltd | ₹ 198.10 | ₹ 2,110 Cr. | 16.4x | 2.3x | 0% | 0% |
| Andrew Yule & Company Ltd | ₹ 21.85 | ₹ 1,081 Cr. | — | 3.9x | 0% | 0% |
| Bombay Super Hybrid Seeds | ₹ 82.90 | ₹ 870 Cr. | 35x | 7.1x | 0% | 0% |
| Mafatlal Industries | ₹ 104.65 | ₹ 755 Cr. | 8.1x | 1.2x | 0% | 0% |
Management
- Amol Gupta
- Chief Financial Officer
- Dhiraj Rajesh Rathi
- Compliance Officer, Company Secretary
- Satish Kagliwal
- Managing Director, Director
- Jeevanlata Nandkishor Kagliwal
- Executive Director
Prices are delayed and for information only. Nothing on this page is investment advice.